366 related articles for article (PubMed ID: 16900006)
1. Prognostic role of dobutamine stress echocardiography in myocardial viability.
Schinkel AF; Poldermans D; Elhendy A; Bax JJ
Curr Opin Cardiol; 2006 Sep; 21(5):443-9. PubMed ID: 16900006
[TBL] [Abstract][Full Text] [Related]
2. Myocardial viability in ischemic heart disease: new directions and perspectives.
Previtali M
Ital Heart J; 2001 Feb; 2(2):93-9. PubMed ID: 11256549
[TBL] [Abstract][Full Text] [Related]
3. Interaction between two predictors of functional outcome after revascularization in ischemic cardiomyopathy: left ventricular volume and amount of viable myocardium.
Mandegar MH; Yousefnia MA; Roshanali F; Rayatzadeh H; Alaeddini F
J Thorac Cardiovasc Surg; 2008 Oct; 136(4):930-6. PubMed ID: 18954632
[TBL] [Abstract][Full Text] [Related]
4. Low-dose dobutamine echocardiography predicts recovery of left ventricular systolic function following revascularization even in presence of low contractile reserve.
Kasliwal RR; Paul B; Mustaqueem A; Bansal M; Trehan N
Indian Heart J; 2006; 58(2):120-5. PubMed ID: 18989055
[TBL] [Abstract][Full Text] [Related]
5. Assessment of myocardial viability with dobutamine stress echocardiography in patients with ischemic left ventricular dysfunction.
Yao SS; Chaudhry FA
Echocardiography; 2005 Jan; 22(1):71-83. PubMed ID: 15660693
[TBL] [Abstract][Full Text] [Related]
6. Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization?
Schinkel AF; Poldermans D; Rizzello V; Vanoverschelde JL; Elhendy A; Boersma E; Roelandt JR; Bax JJ
J Thorac Cardiovasc Surg; 2004 Feb; 127(2):385-90. PubMed ID: 14762345
[TBL] [Abstract][Full Text] [Related]
7. Improvement of stress LVEF rather than rest LVEF after coronary revascularisation in patients with ischaemic cardiomyopathy and viable myocardium.
Rizzello V; Poldermans D; Biagini E; Schinkel AF; van Domburg R; Elhendy A; Vourvouri EC; Bountioukos M; Lombardo A; Krenning B; Roelandt JR; Bax JJ
Heart; 2005 Mar; 91(3):319-23. PubMed ID: 15710710
[TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of hibernating myocardium in ischemic left ventricular dysfunction.
Schinkel AF; Bax JJ; Delgado V; Poldermans D; Rahimtoola SH
Am J Med; 2010 Nov; 123(11):978-86. PubMed ID: 21035587
[TBL] [Abstract][Full Text] [Related]
9. [Myocardial viability in man: state of the art and directions to pursue].
Vanoverschelde JL
Bull Mem Acad R Med Belg; 1999; 154(1):91-6; discussion 96-8. PubMed ID: 10535159
[TBL] [Abstract][Full Text] [Related]
10. Is viability still viable after the STICH trial?
Cortigiani L; Bigi R; Sicari R
Eur Heart J Cardiovasc Imaging; 2012 Mar; 13(3):219-26. PubMed ID: 22080451
[TBL] [Abstract][Full Text] [Related]
11. Assessment of myocardial viability in chronic ischemic heart disease: current status.
Rizzello V; Poldermans D; Bax JJ
Q J Nucl Med Mol Imaging; 2005 Mar; 49(1):81-96. PubMed ID: 15724138
[TBL] [Abstract][Full Text] [Related]
12. Assessment of myocardial viability.
Beller GA
Curr Opin Cardiol; 1997 Sep; 12(5):459-67. PubMed ID: 9352173
[TBL] [Abstract][Full Text] [Related]
13. Assessment of myocardial viability with cardiac magnetic resonance imaging.
Ozben B; Cinçin AA; Mutlu B
Anadolu Kardiyol Derg; 2008 Nov; 8 Suppl 2():71-6. PubMed ID: 19028638
[TBL] [Abstract][Full Text] [Related]
14. Myocardial viability imaging and revascularization in chronic ischemic left ventricular systolic dysfunction.
Tajouri TH; Chareonthaitawee P
Expert Rev Cardiovasc Ther; 2010 Jan; 8(1):55-63. PubMed ID: 20014935
[TBL] [Abstract][Full Text] [Related]
15. Assessment of myocardial viability: review of the clinical significance.
Ramos M; DePasquale E; Coplan NL
Rev Cardiovasc Med; 2008; 9(4):225-31. PubMed ID: 19122580
[TBL] [Abstract][Full Text] [Related]
16. Assessment of myocardial viability in ischemic heart disease by cardiac magnetic resonance imaging.
Muellerleile K; Barmeyer A; Groth M; Lund GK
Minerva Cardioangiol; 2008 Apr; 56(2):237-49. PubMed ID: 18319702
[TBL] [Abstract][Full Text] [Related]
17. Assessment of myocardial viability in ischemic cardiomyopathy.
Bax JJ
Heart Lung Circ; 2005; 14 Suppl 2():S8-13. PubMed ID: 16352289
[TBL] [Abstract][Full Text] [Related]
18. QT dispersion is determined by the relative extent of normal, hibernating, and scarred myocardium in patients with chronic ischemic cardiomyopathy. A dobutamine stress echocardiography study before and after surgical revascularization.
Papadopoulos CE; Zaglavara T; Karvounis HI; Haaverstad R; Parharidis GE; Louridas GE; Kenny A
J Electrocardiol; 2006 Jan; 39(1):103-9. PubMed ID: 16387061
[TBL] [Abstract][Full Text] [Related]
19. Low dose wall motion score predicts the short and long-term benefit of surgical revascularization in patients with ischemic left ventricular dysfunction.
Abdul Ghaffar Y; Maskoun W; Mustafa NG; Feigenbaum H; Sawada SG
Int J Cardiovasc Imaging; 2019 Sep; 35(9):1651-1659. PubMed ID: 31053980
[TBL] [Abstract][Full Text] [Related]
20. Revascularization in severe left ventricular dysfunction: the role of viability testing.
Chareonthaitawee P; Gersh BJ; Araoz PA; Gibbons RJ
J Am Coll Cardiol; 2005 Aug; 46(4):567-74. PubMed ID: 16098417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
